Baker Bros. Advisors »

Generation Bio shares owned by Baker Bros. Advisors

Quarter-by-quarter ownership of Generation Bio (GBIO) shares owned by Baker Bros. Advisors from 13F filings

Historical chart of Baker Bros. Advisors investment in Generation Bio

Tip: Access up to 7 years of quarterly data

All positions including Generation Bio held by Baker Bros. Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Generation Bio by Baker Bros. Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.2M 195k 6.12

More positions owned by Baker Bros. Advisors

BeOne Medicines Sponsored Ads (ONC)
Incyte Corporation (INCY)
Madrigal Pharmaceuticals (MDGL)
Insmed Incorporated Com Par $.01 (INSM)
ACADIA Pharmaceuticals (ACAD)
Summit Therapeutics (SMMT)
Rhythm Pharmaceuticals (RYTM)
Revolution Medicines (RVMD)
Celcuity (CELC)
Kymera Therapeutics (KYMR)
Kodiak Sciences (KOD)
Alkermes SHS (ALKS)
Abcellera Biologics (ABCL)
Edgewise Therapeutics (EWTX)
Kiniksa Pharmaceuticals International Ord Shs Cl A (KNSA)

View all positions for Baker Bros. Advisors

Top funds holding Generation Bio

Renaissance Technologies
Siren
Vanguard Group
Marshall Wace
Baker Bros. Advisors
UBS Group
Acadian Asset Management
Goldman Sachs Group
Yiheng Capital
Cantor Fitzgerald, L. P.
Millennium Management
BlackRock
Geode Capital Management
Citadel Advisors
TD Asset Management

View all funds holding Generation Bio